• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

SAGE Open Med . Minimum infective dose of severe acute respiratory syndrome coronavirus 2 based on the current evidence: A systematic review

tetano

Editor, Senior Moderator
SAGE Open Med


. 2022 Aug 11;10:20503121221115053.
doi: 10.1177/20503121221115053. eCollection 2022.
Minimum infective dose of severe acute respiratory syndrome coronavirus 2 based on the current evidence: A systematic review


SeyedAhmad SeyedAlinaghi[SUP] 1 [/SUP], Amirali Karimi[SUP] 2 [/SUP], Hengameh Mojdeganlou[SUP] 3 [/SUP], Zahra Pashaei[SUP] 1 [/SUP], Pegah Mirzapour[SUP] 1 [/SUP], Ahmadreza Shamsabadi[SUP] 4 [/SUP], Alireza Barzegary[SUP] 5 [/SUP], Fatemeh Afroughi[SUP] 5 6 [/SUP], Soheil Dehghani[SUP] 2 [/SUP], Nazanin Janfaza[SUP] 7 [/SUP], Amirata Fakhfouri[SUP] 5 [/SUP], Sepideh Khodaei[SUP] 1 [/SUP], Esmaeil Mehraeen[SUP] 8 [/SUP], Omid Dadras[SUP] 9 [/SUP]



Affiliations

Abstract

Objective: Understanding the minimum infective dose is significant for risk assessment in the performance of suitable infection control strategies in healthcare centers. However, the literature lacks strong evidence regarding this value for severe acute respiratory syndrome coronavirus 2. Therefore, the aim of this study was to investigate the minimum infectious dose of coronavirus disease 2019.
Methods: We searched the databases of PubMed, Scopus, Web of Science, and Cochrane and retrieved all the relevant literature by 25 July 2021. The records were downloaded into the EndNote software and underwent title/abstract and full-text screenings. A summary of included studies was organized into tables for further analysis, interpretation, and drafting of the results.
Results: Nineteen studies including the laboratory data on human and animal hosts were selected based on the eligibility criteria. All the literature reported on the infective dose, particularly in humans. The main methods for measurement of infection were through tissue culture infectious dose (TCID50) and counting plaque-forming units. The range of minimum infective was 1.26-7 × 10[SUP]6.25[/SUP] PFU.
Conclusion: In this study, we have presented a range of minimum infective doses in humans and various animal species. Such numbers can possibly vary between the individuals based on numerous demographic, immunologic, or other factors.

Keywords: Coronavirus disease 2019; minimum infective dose; severe acute respiratory syndrome coronavirus 2.
 
Back
Top Bottom